DOCSLIB.ORG

Glycemic Status, Insulin Resistance, and Risk of Pancreatic Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Glycemic Status, Insulin Resistance, and Risk of Pancreatic Cancer 1840 ARTICLE Glycemic Status, Insulin Resistance, and Risk of Pancreatic Cancer Mortality in Individuals With and Without Diabetes PANCREAS Nam Hee Kim, MD, PhD1, Yoosoo Chang, MD, PhD2,3,4, Sung Ryol Lee, MD, PhD5, Seungho Ryu, MD, PhD2,3,4 and Hong Joo Kim, MD, PhD1 INTRODUCTION: The impact of glycemic status and insulin resistance on the risk of pancreatic cancer in the nondiabetic 11/05/2020 on BhDMf5ePHKbH4TTImqenVA+lpWIIBvonhQl60Etgtdnn9T1vLQWJq/+R2O4Kjt58 by http://journals.lww.com/ajg from Downloaded population remains uncertain. We aimed to examine the association of glycemic status and insulin Downloaded resistance with pancreatic cancer mortality in individuals with and without diabetes. from METHODS: This is a cohort study of 572,021 Korean adults without cancer at baseline, who participated in repeat http://journals.lww.com/ajg screening examinations which included fasting blood glucose, hemoglobin A1c, and insulin, and were followed for a median of 8.4 years (interquartile range, 5.3 -13.2 years). Vital status and pancreatic cancer mortality were ascertained through linkage to national death records. by RESULTS: BhDMf5ePHKbH4TTImqenVA+lpWIIBvonhQl60Etgtdnn9T1vLQWJq/+R2O4Kjt58 During 5,211,294 person-years of follow-up, 260 deaths from pancreatic cancer were identified, with a mortality rate of 5.0 per 105 person-years. In the overall population, the risk of pancreatic cancer mortality increased with increasing levels of glucose and hemoglobin A1c in a dose-response manner, and this association was observed even in individuals without diabetes. In nondiabetic individuals without previously diagnosed or screen-detected diabetes, insulin resistance and hyperinsulinemia were positively associated with increased pancreatic cancer mortality. Specifically, the multivariable- adjusted hazard ratio (95% confidence intervals) for pancreatic cancer mortality comparing the homeostatic model assessment of insulin resistance ‡75th percentile to the <75th percentile was 1.49 (1.08–2.05), and the corresponding hazard ratio comparing the insulin ‡75th percentile to the <75th percentile was 1.43 (1.05–1.95). These associations remained significant when introducing changes in insulin resistance, hyperinsulinemia, and other confounders during follow-up as time-varying covariates. DISCUSSION: Glycemic status, insulin resistance, and hyperinsulinemia, even in individuals without diabetes, were on 11/05/2020 independently associated with an increased risk of pancreatic cancer mortality. SUPPLEMENTARY MATERIAL accompanies this paper at http://links.lww.com/AJG/B680 Am J Gastroenterol 2020;115:1840–1848. https://doi.org/10.14309/ajg.0000000000000956 INTRODUCTION Accumulating evidence indicates a positive association be- Pancreatic cancer is a highly lethal disease and the seventh tween diabetes and the risk of pancreatic cancer, but whether leading cause of cancer-related deaths worldwide (1–3). The diabetes is etiologically involved in pancreatic carcinogenesis incidence of pancreatic cancer has increased slightly over the remains controversial (5–9). Epidemiological and clinical studies past decade, and the 5-year survival rates remain as low as indicate that patients with diabetes have an almost 2-fold in- 3%–15% despite multidisciplinary therapies (1,4). Therefore, the creased risk of incident pancreatic cancer (10,11) and pancreatic identification of modifiable risk factors is important to establish a cancer mortality (12), and they also have a higher mortality rate preventive strategy to reduce morbidity and mortality from pan- with shorter median survival compared with those without di- creatic cancer. abetes (13). In addition, several studies have found that fasting 1Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 2Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 3Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 4Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea; 5Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Correspondence: Hong Joo Kim, MD, PhD. E-mail: hongjoo3.kim@ samsung.com. Seungho Ryu, MD, PhD. E-mail: [email protected]. Received April 28, 2020; accepted August 24, 2020; published online September 30, 2020 The American Journal of GASTROENTEROLOGY VOLUME 115 | NOVEMBER 2020 www.amjgastro.com Copyright © 2020 by The American College of Gastroenterology. Unauthorized reproduction of this article is prohibited. Glucose Metabolism and Pancreatic Cancer Mortality 1841 blood glucose (FBG), postload plasma glucose, random plasma glucose, or hemoglobin A1c (HbA1c) has a dose-response re- lationship with the risk of pancreatic cancer, and this association was seen even in the nondiabetic range of blood markers for glucose metabolism (8,11,14,15). In contrast, a recent mendelian randomization study did not support a causal relationship be- tween type 2 diabetes and pancreatic cancer, but suggested a causal role of body mass index (BMI) and fasting insulin in pancreatic cancer etiology (9). Insulin resistance and compensatory hyperinsulinemia are key pathogenic features of diabetes and can be an important mediator PANCREAS that links diabetes to pancreatic cancer (16,17). In several pro- spective studies, individuals with elevated levels of insulin, pro- insulin, and nonfasting C peptide were found to have a significantly Figure 1. Flowchart of study participants. increased risk of pancreatic cancer, suggesting that insulin re- sistance confers an increased risk of pancreatic cancer (18–20). Measurements and definitions of variables Experimental evidence suggests that high levels of insulin promote Information on demographic characteristics, behavioral factors, proliferation and reduce apoptosis in pancreatic cancer cells medical history, and medication use was collected using a stan- (21,22). However, it remains unclear whether insulin resistance dardized, self-administered questionnaire as described previously and hyperinsulinemia would influence the risk of pancreatic cancer (25,26). Participants were categorized by smoking status as never, in individuals without diabetes. Indeed, insulin resistance and former, and current smokers. Current alcohol use was assessed as hyperinsulinemia precede prediabetes and type 2 diabetes (15,23) the frequency of alcohol drinking per week and the amount of and are more likely to be improved and corrected through lifestyle alcohol consumed per drinking day and categorized into none, modification in the prediabetes stage (15,24). Thus, it is of great ,20, and $20 g of ethanol/d. The weekly frequency of moderate clinical significance to determine whether insulin resistance and or vigorous physical activity was also assessed and categorized as hyperinsulinemia are associated with the risk of pancreatic cancer ,3 and $3 times/wk. A family history of cancer was defined as and its prognosis even in individuals without diabetes. having one or more first-degree relatives with any type of cancer Therefore, the aim of the current study was to investigate the disclosed in a self-reported questionnaire. associations of glycemic status, insulin resistance, and insulin Sitting blood pressure (BP), height, and weight were measured with pancreatic cancer mortality in a large sample of Korean by trained nurses. Overweight was defined as BMI $23 kg/m2, adults and to examine whether these associations exist among according to the proposed cutoff foradiagnosisofobesityinAsians people without diabetes. (27). Hypertension was defined as systolic BP $140 mm Hg, di- astolic BP $90 mm Hg, or use of antihypertensive medication. METHODS Blood tests were measured after at least 10 hours of fasting and Study population included lipid profiles (total cholesterol, low-density lipoprotein This cohort study was a part of the Kangbuk Samsung Health cholesterol, high-density lipoprotein cholesterol, and triglycer- Study, a cohort study of Korean men and women who underwent a ides), alanine aminotransferase, gamma-glutamyltransferase, comprehensive annual or biennial health examination at one of the high-sensitivity C-reactive protein (hsCRP), and markers of Kangbuk Samsung Hospital Total Healthcare Center clinics in glucose metabolism including FBG, HbA1c, and insulin. Serum Seoul and Suwon, South Korea (25,26). In Korea, annual or bi- insulin levels were measured on the day of blood collection by ennial health-screening examinations of employees are required by immunoradiometric assays (Biosource, Nivelles, Belgium) be- the Industrial Safety and Health Law. Over 80% of participants tween 2002 and 2009 and thereafter by using an electro- were employees or spouses of employees of various companies chemiluminescence immunoassay with the Modular E170 system or local governmental organizations. The rest of the partici- (Roche Diagnostics, Tokyo, Japan). Insulin resistance was pants voluntarily purchased the health checkup program. assessed using the homeostatic model assessment of insulin re- This study population included individuals who participated sistance (HOMA-IR) equation as follows: fasting blood insulin in a comprehensive health-screening examination between 2002 (IU/L) 3 FBG (mg/dL)/405,
Load more

Recommended publications
  • Dietary Modulation of Insulin and Glucose in Prediabetes
    24 Review Article Volume 25, Number 1, 2010 JOM Dietary Modulation of Insulin and Glucose in Prediabetes Author: Jack Challem Post O!ce Box 30246, Tucson AZ 85751 USA www.jackchallem.com Abstract Prediabetes is usually intertwined with overweight, and both conditions presage type 2 diabetes, coronary artery disease, and many other common diseases. Early signs of prediabetes include abdominal adiposity, mood swings, sugar and carbohydrate cravings, and feeling tired or mentally fuzzy after eating. Standard measures of glucose intolerance, such as fasting glucose, may reveal a “false normal” when a person is actually prediabetic. Combined with tests for glucose, fasting insulin becomes a powerful predictor of type 2 diabetes and sequelae 10 to 15 years before glucose becomes elevated. Such an early warning provides a window to implement dietary changes to restore nor- mal glucose tolerance. Adopting a Paleolithic-style diet that emphasizes fresh, low-fat animal pro- teins and high-fiber vegetables can usually reverse prediabetes. Furthermore, dietary supplements can enhance insulin sensitivity and/or glucose control. !ese supplements include alpha-lipoic acid, chromium, biotin, silymarin, vitamin D3 combined with calcium, and vitamin K. Prediabetes is an opportunity to improve health, and it is wise to seize this opportunity. Not doing so will eventually lead to type 2 diabetes, which is far more difficult to reverse and almost always requires some form of pharmaceutical intervention. Introduction year, one million Americans graduate from Prediabetes, not influenza, is the true prediabetes to type 2 diabetes. Similar trends pandemic. It is intertwined with overweight, are occurring in Canada.1 and both conditions presage type 2 diabetes Depending on the diagnostic test used, mellitus and many other health problems.
    [Show full text]
  • Effect of Almond Consumption on Metabolic Risk Factors
    CLINICAL TRIAL published: 24 June 2021 doi: 10.3389/fnut.2021.668622 Effect of Almond Consumption on Metabolic Risk Factors—Glucose Metabolism, Hyperinsulinemia, Selected Markers of Inflammation: A Randomized Controlled Trial in Adolescents and Young Adults Jagmeet Madan 1, Sharvari Desai 1, Panchali Moitra 1, Sheryl Salis 2, Shubhada Agashe 3, Rekha Battalwar 1, Anushree Mehta 4, Rachana Kamble 4, Soumik Kalita 5*, Ajay Gajanan Phatak 6, Shobha A. Udipi 4,7, Rama A. Vaidya 8 and Ashok B. Vaidya 4 1 Sir Vithaldas Thackersey College of Home Science (Autonomous), Shreemati Nathibai Damodar Thackersey (SNDT) Women’s University, Mumbai, India, 2 Nurture Health Solutions, Mumbai, India, 3 Clinical and Endocrine Laboratory, Kasturba 4 Edited by: Health Society Medical Research Centre, Mumbai, India, Kasturba Health Society Medical Research Centre, Mumbai, India, 5 6 7 Maria Hassapidou, FamPhy, Gurgaon, India, Charutar Arogya Mandal, Karamsad, India, Department of Food Science and Nutrition, 8 International Hellenic Shreemati Nathibai Damodar Thackersey (SNDT) Women’s University, Mumbai, India, Division of Endocrine and Metabolic University, Greece Disorders, Kasturba Health Society Medical Research Centre, Mumbai, India Reviewed by: Costas A. Anastasiou, A large percentage of the Indian population has diabetes or is at risk of pre-diabetes. Harokopio University, Greece Almond consumption has shown benefits on cardiometabolic risk factors in adults. Vibeke H. Telle-Hansen, Oslo Metropolitan University, Norway This study explored the effect of
    [Show full text]
  • Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress
    cancers Review Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress Stefano Menini 1,† , Carla Iacobini 1,†, Martina Vitale 1, Carlo Pesce 2 and Giuseppe Pugliese 1,* 1 Department of Clinical and Molecular Medicine, “La Sapienza” University, 00189 Rome, Italy; [email protected] (S.M.); [email protected] (C.I.); [email protected] (M.V.) 2 Department of Neurosciences, Rehabilitation, Ophtalmology, Genetic and Maternal Infantile Sciences (DINOGMI), Department of Excellence of MIUR, University of Genoa Medical School, 16132 Genoa, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-03-3377-5440 † These authors contributed equally to this work. Simple Summary: Diabetic people have an increased risk of developing several types of cancers, particularly pancreatic cancer. The higher availability of glucose and/or lipids that characterizes diabetes and obesity is responsible for the increased production of highly reactive carbonyl com- pounds, a condition referred to as “carbonyl stress”. Also known as glycotoxins and lipotoxins, these compounds react quickly and damage various molecules in cells forming final products termed AGEs (advanced glycation end-products). AGEs were shown to markedly accelerate tumor development in an experimental model of pancreatic cancer and AGE inhibition prevented the tumor-promoting effect of diabetes. In humans, carbonyl stress has been associated with the risk of pancreatic cancer and recognized as a possible contributor to other cancers, including breast and colorectal cancer. These findings suggest that carbonyl stress is involved in cancer development and growth and may be the mechanistic link between diabetes and pancreatic cancer, thus representing a potential drug target.
    [Show full text]
  • Insulin Resistance and the Polycystic Ovary Syndrome
    HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT Endocrine Reviews 18 (6): 774-800 Abstract of this Article ( ) Copyright © 1997 by The Endocrine Society Reprint (PDF) Version of this Article Insulin Resistance and the Similar articles found in: Polycystic Ovary Syndrome: Endocrine Reviews Online PubMed Mechanism and Implications 1 for Pathogenesis PubMed Citation Andrea Dunaif This Article has been cited by: Pennsylvania State University College of Medicine, Hershey, other online articles Pennsylvania 17033 Search PubMed for articles by: Dunaif, A. Alert me when: new articles cite this article Download to Citation Manager Top Abstract I. Introduction II. Insulin Action in... III. Hypotheses Explaining the... IV. Clinical Implications of... V. Summary References Abstract I. Introduction A. Background and historical perspective B. Definition of PCOS II. Insulin Action in PCOS A. Glucose tolerance B. Insulin action in vivo in PCOS C. Insulin secretion in PCOS D. Insulin clearance in PCOS E. Cellular and molecular mechanisms of insulin resistance F. Constraints of insulin action studies in PCOS G. PCOS as a unique NIDDM subphenotype III. Hypotheses Explaining the Association of Insulin Resistance and PCOS A. Causal association B. Possible genetic association of PCOS and insulin resistance IV. Clinical Implications of Insulin Resistance in PCOS A. Clinical diagnosis of insulin resistance B. Other metabolic disorders in PCOS C. Therapeutic considerations V. Summary Top Abstract I. Introduction II. Insulin Action in... III. Hypotheses Explaining the... IV. Clinical Implications of... V. Summary References I. Introduction A. Background and historical perspective POLYCYSTIC ovary syndrome (PCOS) is an exceptionally common disorder of premenopausal women characterized by hyperandrogenism and chronic anovulation (1, 2).
    [Show full text]
  • Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma
    www.nature.com/scientificreports OPEN Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted Received: 1 November 2017 Accepted: 27 March 2018 by Diet-induced Obesity in the Published: xx xx xxxx Conditional KrasG12D Mouse Model Hui-Hua Chang 1, Aune Moro1, Caroline Ei Ne Chou1, David W. Dawson2, Samuel French 2, Andrea I. Schmidt1,3, James Sinnett-Smith4, Fang Hao4, O. Joe Hines1, Guido Eibl 1 & Enrique Rozengurt4 Pancreatic ductal adenocarcinoma (PDAC) is a particularly deadly disease. Chronic conditions, including obesity and type-2 diabetes are risk factors, thus making PDAC amenable to preventive strategies. We aimed to characterize the chemo-preventive efects of metformin, a widely used anti-diabetic drug, on PDAC development using the KrasG12D mouse model subjected to a diet high in fats and calories (HFCD). LSL-KrasG12D/+;p48-Cre (KC) mice were given control diet (CD), HFCD, or HFCD with 5 mg/ml metformin in drinking water for 3 or 9 months. After 3 months, metformin prevented HFCD-induced weight gain, hepatic steatosis, depletion of intact acini, formation of advanced PanIN lesions, and stimulation of ERK and mTORC1 in pancreas. In addition to reversing hepatic and pancreatic histopathology, metformin normalized HFCD-induced hyperinsulinemia and hyperleptinemia among the 9-month cohort. Importantly, the HFCD-increased PDAC incidence was completely abrogated by metformin (p < 0.01). The obesogenic diet also induced a marked increase in the expression of TAZ in pancreas, an efect abrogated by metformin. In conclusion, administration of metformin improved the metabolic profle and eliminated the promoting efects of diet-induced obesity on PDAC formation in KC mice.
    [Show full text]
  • Hyperinsulinemia 101
    HYPERINSULINEMIA 101 Melanie Nelson & Kory Seder Good Food Low Carb Cafe “I can make you fat. I can make anybody fat. I just need to give enough insulin.” –Dr. Jason Fung Canadian nephrologist, founder of Intensive Dietary Management, author, and world-leading expert on intermittent fasting and LCHF, especially for treating people with type 2 diabetes. INSULIN • Insulin: Hormone released by the pancreas after meals that allows your cells to use glucose for energy. Insulin is also the body’s main fat storage hormone & involved in many biochemical regulatory processes. • Insulin Resistance (IR): decreased sensitivity of the body’s cells to insulin. If someone is IR they require ever-MORE insulin to bring down high circulating blood sugar levels after carbohydrate-rich meals. • Hyperinsulinemia: condition of chronic elevated levels of insulin in the blood. • Reactive Hypoglycemia: Low blood sugar levels after eating caused by hyperinsulinemia. An early indicator of insulin resistance and metabolic syndrome. • Metabolic Syndrome: Insulin Resistance Syndrome Metabolic Syndrome is Hyperinsulinemia! How many of you in this room have ever had your Insulin levels measured? How did we get to this diabetes & obesity epidemic? “Senators don't have the luxury that a research scientist does of waiting until every last shred of evidence is in.” - Senator George McGovern, 1977 Ignoring a lack of evidence, it was agreed that the USDA would draft official low-fat & low-cholesterol dietary guidelines for Americans (1980) using the non-expert McGovern Report (1977) as a substrate. “Healthcare is rife with controversy, and the field of nutrition more so than many, characterised as it is by much weak science, polarised opinion, and powerful commercial interests.[4] But nutrition is perhaps one of the most important and neglected of all health disciplines, traditionally relegated to non-medical nutritionists rather than being, as we believe it deserves to be, a central part of medical training and practice.
    [Show full text]
  • KCNQ1 Long QT Syndrome Patients Have Hyperinsulinemia and Symptomatic
    Page 1 of 35 Diabetes 1 1 KCNQ1 Long QT syndrome patients have hyperinsulinemia and symptomatic 2 hypoglycemia 3 Running title: Hyperinsulinemia and hypoglycemia in KCNQ1 LQTS 4 5 Signe S. Torekov, PhD1,2; Eva Iepsen, MD1,2; Michael Christiansen, MD3, Allan Linneberg, 6 PhD4; Oluf Pedersen, DMSci1,2,5; Jens J. Holst, DMSci1,2; Jørgen K. Kanters, PhD1,6; Torben 7 Hansen, PhD2,7 8 1Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of 9 Copenhagen, 2200 Copenhagen, Denmark, 2Novo Nordisk Foundation Center for Basic Metabolic 10 Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen. 11 3Department of Clinical Biochemistry, SSI, 2300 Copenhagen, 4Research Centre for Prevention and 12 Health, Glostrup University Hospital, 2600 Glostrup, 5Faculty of Health Sciences, University of 13 Aarhus, 8000 Aarhus, Denmark. Denmark. 6Gentofte, Aalborg & Herlev University Hospitals, 2950 14 Hellerup, Denmark, 7Faculty of Health Sciences, University of Southern Denmark, 5230 Odense, 15 Denmark. 16 17 Corresponding author 18 Signe S. Torekov, Assistant Professor, PhD 19 Department of Biomedical Sciences and Novo Nordisk Foundation Center for Basic Metabolic 20 Research, Faculty of Health and Medical Sciences, University of Copenhagen, 21 Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark, TEL +45 353 27509, 22 [email protected] 23 24 Word count: 3,857 words, 6 figures, 2 tables and Supplementary appendix (2 tables and 1 figure) Diabetes Publish Ahead of Print, published online December 18, 2013 Diabetes Page 2 of 35 2 1 Patients with loss of function mutations in KCNQ1 have KCNQ1 long QT syndrome (LQTS). 2 KCNQ1 encodes a voltage-gated K+ channel located in both cardiomyocytes and pancreatic beta 3 cells.
    [Show full text]
  • Substituting Poly and Mono-Unsaturated Fat for Dietary
    ition & F tr oo u d N f S o c l i e a n n c r e u s o J Journal of Nutrition & Food Sciences McLaughlin T et al., J Nutr Food Sci 2015, 5:6 ISSN: 2155-9600 DOI: 10.4172/2155-9600.1000429 Research Article Open Access Substituting Poly and Mono-unsaturated Fat for Dietary Carbohydrate Reduces Hyperinsulinemia in Women with Polycystic Ovary Syndrome Perelman D, Coghlan N#, Lamendola C, Carter S, Abbasi F and McLaughlin T* Division of Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, Rm S025 Stanford, CA, 94305-5103, USA. #Currently at the San Jose Medical Group: 2585 Samaritan Drive, San Jose, CA 95124, USA. *Corresponding author: McLaughlin T, Division of Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, Rm S025, Stanford, CA 94305-5103, Tel: 650-723-3186; Fax: 650-725-7085; E-mail: [email protected] Rec date: Sep 29, 2015; Acc date: Nov 12, 2015; Pub date: Nov 19, 2015 Copyright: © 2015 Perelman D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Objective: Hyperinsulinemia is a prevalent feature of Polycystic Ovary Syndrome (PCOS), contributing to metabolic and reproductive manifestations of the syndrome. Weight loss reduces hyperinsulinemia but weight regain is the norm, thus preventing long-term benefits. In the absence of weight loss, replacement of dietary carbohydrate (CHO) with mono/polyunsaturated fat reduces ambient insulin concentrations in non-PCOS subjects.
    [Show full text]
  • Initial Hyperinsulinemia and Subsequent Β-Cell Dysfunction Is Associated with Elevated Palmitate Levels
    nature publishing group Translational Investigation Articles Initial hyperinsulinemia and subsequent β-cell dysfunction is associated with elevated palmitate levels Johan Staaf1,2, Sarojini J.K.A. Ubhayasekera3, Ernest Sargsyan1, Azazul Chowdhury1, Hjalti Kristinsson1, Hannes Manell1,2, Jonas Bergquist3, Anders Forslund2 and Peter Bergsten1 BACKGROUND: The prevalence of obesity-related diabetes in obesity with T2DM (5). High NEFA concentrations are observed childhood is increasing and circulating levels of nonesterified in both obese adults (5,6) and children (7) and have been asso- fatty acids may constitute a link. Here, the association between ciated with insulin secretion in vivo (8,9). Among circulating palmitate and insulin secretion was investigated in vivo and NEFAs, the saturated fatty acid palmitate (C16:0) is one of the in vitro. most abundant (10). Palmitate has previously been associated METHODS: Obese and lean children and adolescents (n = 80) with both postprandial insulin secretion and insulin sensitivity were included. Palmitate was measured at fasting; insulin and in vivo (11) and extensively investigated in vitro in connection glucose during an oral glucose tolerance test (OGTT). Human with decline in islet β-cell function and mass after prolonged islets were cultured for 0 to 7 d in presence of 0.5 mmol/l pal- exposure (12). Detrimental effects of chronic palmitate expo- mitate. Glucose-stimulated insulin secretion (GSIS), insulin con- sure include shifts in sphingolipid metabolism as well as ini- tent and apoptosis were measured. tiation of oxidative stress, downregulation of glucokinase, and RESULTS: Obese subjects had fasting palmitate levels triggering of endoplasmic reticulum-stress response (13–18). between 0.10 and 0.33 mmol/l, with higher average levels In addition, palmitate contributes to inhibition of insulin pro- compared to lean subjects.
    [Show full text]
  • Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin Production
    Cell Metabolism Article Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin Production Arya E. Mehran,1,2 Nicole M. Templeman,1,2 G. Stefano Brigidi,1 Gareth E. Lim,1,2 Kwan-Yi Chu,1,2 Xiaoke Hu,1,2 Jose Diego Botezelli,1,2 Ali Asadi,1,2 Bradford G. Hoffman,2 Timothy J. Kieffer,1,2 Shernaz X. Bamji,1 Susanne M. Clee,1 and James D. Johnson1,2,* 1Department of Cellular and Physiological Sciences 2Department of Surgery University of British Columbia, Vancouver, BC V6T 1Z3, Canada *Correspondence: [email protected] http://dx.doi.org/10.1016/j.cmet.2012.10.019 SUMMARY obesity. Fat-specific insulin receptor knockout mice are pro- tected from diet-induced obesity and have extended longevity Hyperinsulinemia is associated with obesity and (Blu¨ her et al., 2002; Katic et al., 2007), whereas elimination of pancreatic islet hyperplasia, but whether insulin insulin receptors from some, but not all, brain regions increases causes these phenomena or is a compensatory food intake and obesity (Bru¨ ning et al., 2000; Ko¨ nner and Bru¨ n- response has remained unsettled for decades. We ing, 2012). The interpretation of studies involving insulin receptor examined the role of insulin hypersecretion in diet- ablation is confounded by compensation between tissues and induced obesity by varying the pancreas-specific disruption of insulin-like growth factor signaling involving hybrid receptors (Blu¨ her et al., 2002; Kitamura et al., 2003). Moreover, Ins1 gene dosage in mice lacking Ins2 gene expres- knockout of the insulin receptor, by definition, induces tissue- sion in the pancreas, thymus, and brain.
    [Show full text]
  • Endogenous Insulin Contributes to Pancreatic Cancer Development
    bioRxiv preprint doi: https://doi.org/10.1101/530097; this version posted January 24, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Endogenous insulin contributes to pancreatic cancer development Anni M.Y. Zhang1, Jamie Magrill1, Twan J.J. de Winter1, Xiaoke Hu1, Søs Skovsø1, David F. 2 1 1 Schaeffer , Janel L. Kopp *, and James D. Johnson * Keywords: PDAC, hyperinsulinemia, obesity, type 2 diabetes Obesity and early-stage type 2 diabetes (T2D) increase the risk for many cancers, including pancreatic ductal adenocarcinoma (PDAC). The mechanisms linking obesity and T2D to cancer have not been established, preventing targeted interventions. Arguments have been made that hyperinsulinemia, hyperglycemia, or inflammation could drive cancer initiation and/or progression1. Hyperinsulinemia is a cardinal feature of obesity and T2D, and is independently associated with PDAC incidence and mortality2-4, even in non-obese people5. Despite ample human epidemiological evidence linking hyperinsulinemia to PDAC, there is no direct in vivo evidence of a causal role for endogenous insulin in cancer in any system. Using mice with reduced insulin gene dosage6,7, we show here that a modest reduction in endogenous insulin production leads to a ~50% reduction in pancreatic intraepithelial neoplasia (PanIN) pre-cancerous lesions in high fat diet-fed mice expressing the KrasG12D oncogene8. The significant reduction in PanIN lesions occurred in the absence of changes in fasting glucose. Reduced insulin also led to a ~50% reduction in pancreatic fibrosis, suggesting that endogenous insulin drives PanIN development, in part, via its pro-fibrotic effects on the stroma surrounding acinar cells and PanIN.
    [Show full text]
  • The Metabolic Syndrome: Time for a Critical Appraisal Joint Statement from the American Diabetes Association and the European Association for the Study of Diabetes
    Reviews/Commentaries/ADA Statements ADA STATEMENT The Metabolic Syndrome: Time for a Critical Appraisal Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes 1 3 RICHARD KAHN, PHD ELE FERRANNINI, MD seemed clearly related to type 2 diabetes 2 4 JOHN BUSE, MD, PHD MICHAEL STERN, MD (15). This risk factor clustering, and its as- sociation with insulin resistance, led in- vestigators to propose the existence of a unique pathophysiological condition, The term “metabolic syndrome” refers to a clustering of specific cardiovascular disease (CVD) called the “metabolic” (1–3) or “insulin risk factors whose underlying pathophysiology is thought to be related to insulin resistance. resistance” (11) syndrome. This concept Since the term is widely used in research and clinical practice, we undertook an extensive review was unified and extended with the land- of the literature in relation to the syndrome’s definition, underlying pathogenesis, and associa- mark publication of Reaven’s 1988 tion with CVD and to the goals and impact of treatment. While there is no question that certain CVD risk factors are prone to cluster, we found that the metabolic syndrome has been impre- Banting Medal award lecture (16). Reaven cisely defined, there is a lack of certainty regarding its pathogenesis, and there is considerable postulated that insulin resistance and its doubt regarding its value as a CVD risk marker. Our analysis indicates that too much critically compensatory hyperinsulinemia predis- important information is missing to warrant its designation as a “syndrome.” Until much needed posed patients to hypertension, hyperlip- research is completed, clinicians should evaluate and treat all CVD risk factors without regard to idemia, and diabetes and thus was the whether a patient meets the criteria for diagnosis of the “metabolic syndrome.” underlying cause of much CVD.
    [Show full text]